| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |